Low-Dose Gadobenate Dimeglumine Versus Standard-Dose Gadopentate Dimeglumine for Delayed Contrast-Enhanced Cardiac Magnetic Resonance Imaging

Academic Radiology

Volumn 13, Issue 7, 2006, Pages 833-839

  Balci, Numan C ^a,b   Inan, Nagihan ^b   Anik, Yonca ^b   Erturk, Mehmet S ^c   Ural, Dilek ^b   Demirci, Ali ^b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KOCAELI UNIVERSITY   (Turkey)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

cardiac; contrast agent; MRI; viability

Indexed keywords

CONTRAST MEDIUM; GADOBENATE DIMEGLUMINE; GADOPENTATE DIMEGLUMINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EVALUATION; FEMALE; HEART INFARCTION; HEART MUSCLE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS;

AGED; CONTRAST MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEGLUMINE; MIDDLE AGED; MYOCARDIAL INFARCTION; ORGANOMETALLIC COMPOUNDS; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 33744998674     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acra.2006.04.002     Document Type: Article

References (12)

1. Spinazzi A., Lorusso V., Pirovano G., et al. MultiHance clinical pharmacology. biodistribution and MR enhancement of the liver. Acad Radiol 5 Suppl 1 (1998) S86-S92
2. Spinazzi A., Lorusso V., Pirovano G., et al. Safety, tolerance, biodistribution and MR imaging enhancement of the liver with gadobenate dimeglumine. Acad Radiol 6 (1999) 282-291
3. Kirchin M.A., Pirovano G., and Spinazzi A. Gadobenate dimeglumine (Gd- BOPTA). an overview. Invest Radiol 33 (1998) 798-809
4. Petersein J., Spinazzi A., Giovagnoni A., et al. Evaluation of the efficacy of gadobenate dimeglumine in MR imaging of focal liver lesions. a multicenter Phase III clinical study. Radiology 215 (2000) 727-730
5. Schneider G., Maas R., Kool L.S., Rummen E., et al. Low-dose gadobenate dimeglumine versus standard dose gadopentetate dimeglumine for contrast-enhanced magnetic resonance imaging of the liver. an intra-individual crossover comparison. Invest Radiol 38 (2003) 85-94
6. Simonetti O.P., Kim R.J., Fieno D.S., et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 218 (2001) 215-223
7. Kim R.J., Fieno D.S., Parrish T.B., et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 100 (1999) 1992-2002
8. Kuwatsuru R., Kadoya M., Ohtomo K., et al. Comparison of gadobenate dimeglumine with gadopentetate dimeglumine for MR imaging of liver tumors. Invest Radiol 36 (2001) 632-641
9. Cerqueira M.D., Weissman N.J., Dilsizian V., et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105 (2002) 539-542
10. Essig M., Hartmann M., Lodemann K.-P., et al. Comparison of Gd-BOPTA and Gd-DTPA for contrast-enhanced MRI of intra-axial cerebral tumors. a two-center, double-blind randomized, intraindividual crossover study. Radiologe 41 (2001) 1063-1071
11. Kroenke T.J., Wasser M.N., Pattynama P.M.T., et al. Gadobenate dimeglumine-enhanced MR angiography of the abdominal aorta and renal arteries. AJR Am J Roentgenol 179 (2002) 1573-1582
12. Gupta A, Lee VS, Chung Y-C, et al. Myocardial infarction: optimization of inversion times at delayed contrast-enhanced MR imaging radiology 2004; 233:921-926.